BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 15503066)

  • 1. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.
    Souza HS; Neves MS; Elia CC; Tortori CJ; Dines I; Martinusso CA; Madi K; Andrade L; Castelo-Branco MT
    World J Gastroenterol; 2006 Oct; 12(38):6133-41. PubMed ID: 17036384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
    Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
    Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis.
    Suzuki A; Sugimura K; Ohtsuka K; Hasegawa K; Suzuki K; Ishizuka K; Mochizuki T; Honma T; Narisawa R; Asakura H
    Scand J Gastroenterol; 2000 Dec; 35(12):1278-83. PubMed ID: 11199367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis.
    Yukawa M; Iizuka M; Horie Y; Yoneyama K; Shirasaka T; Itou H; Komatsu M; Fukushima T; Watanabe S
    Int J Colorectal Dis; 2002 Mar; 17(2):70-6. PubMed ID: 12014424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
    Ueyama H; Kiyohara T; Sawada N; Isozaki K; Kitamura S; Kondo S; Miyagawa J; Kanayama S; Shinomura Y; Ishikawa H; Ohtani T; Nezu R; Nagata S; Matsuzawa Y
    Gut; 1998 Jul; 43(1):48-55. PubMed ID: 9771405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
    Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
    Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
    Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
    Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease.
    Müller S; Lory J; Corazza N; Griffiths GM; Z'graggen K; Mazzucchelli L; Kappeler A; Mueller C
    Am J Pathol; 1998 Jan; 152(1):261-8. PubMed ID: 9422543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD).
    Ciccocioppo R; Di Sabatino A; Parroni R; D'alò S; Pistoia MA; Doglioni C; Cifone MG; Corazza GR
    Clin Exp Immunol; 2000 May; 120(2):235-40. PubMed ID: 10792370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal regulation of galectin-1-induced T-cell death in lamina propria from Crohn's disease and ulcerative colitis patients.
    Papa-Gobbi R; Muglia CI; Rocca A; Curciarello R; Sambuelli AM; Yantorno M; Correa G; Morosi LG; Di Sabatino A; Biancheri P; MacDonald TT; Toscano MA; Mariño KV; Rabinovich GA; Docena GH
    Apoptosis; 2021 Jun; 26(5-6):323-337. PubMed ID: 33978920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis.
    Kokkonen TS; Karttunen TJ
    J Histochem Cytochem; 2015 Dec; 63(12):931-42. PubMed ID: 26374830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.